Corrigendum to "Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile" [Pharmacol. Res. 110 (August 2016) (2016) 205-215].
| Image |  |
|---|---|
| Description | scientific article published on 19 April 2017 |
| Author/s |
author: María R Pazos Moisés García-Arencibia Eduardo Munoz Paula Morales |
| Publication date | April 20, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |